N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties

Publication | Open Access

DOI Full Paper Access

249

Citations

References

2003

Year

Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu, Mohamed Hachicha, Lori Schmid, Laykea Tafesse, Qun Sun, Yakov Rotshteyn, Joseph W. Francis, James T. Limberis,

Journal of Pharmacology and Experimental Therapeutics